甲状腺功能亢进性心脏病并心房颤动的诊治进展

Progress in Diagnosis and Treatment of Hyperthyroid Heart Disease and Atrial Fibrillation

甲状腺功能亢进性心脏病并心房颤动非常常见,给患者带来了很大的负担,其发病机制有待于进一步探讨,诊治上除治疗原发病之外,心房颤动是重点。控制快速的心房颤动心室率可使用β受体阻滞剂、地高辛及维拉帕米等,必要时实施电复律。另外,不可忽视抗栓塞防治,使用华法林、阿司匹林等药物进行抗凝治疗,如何更好地防止甲状腺功能亢进时心房颤动的发生以及带来的相关危害,降低致残率、致死率,值得进一步研究。

Hyperthyroid heart disease（HHD） is frequently associated with atrial fibrillation（AF）,which adversely impacts on patients.The pathogenesis of HHD-AF requires further investigation.In addition to the management of the primary disease,the control of AF is another target.Rapid ventricular rate in AF can be controlled by the use of beta receptor blocker,digoxin,verapamil,and even cardioconversion in case of need.Additionally,the prevention of embolization should be also in place,including the anticoagulation with warfarin and aspirin.How to effectively prevent the occurrence of HHD-AF and consequent risks is of great significance for the minimization of disability and mortality.